These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 1610485

  • 1. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW, Tancer ME, Rubinow DR, Roscow DB, Boulenger JP, Vittone B, Gurguis G, Geraci M, Black B, Post RM.
    Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485
    [Abstract] [Full Text] [Related]

  • 2. Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder.
    Tancer ME, Stein MB, Black B, Uhde TW.
    Am J Psychiatry; 1993 Feb; 150(2):336-7. PubMed ID: 8422091
    [Abstract] [Full Text] [Related]

  • 3. Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder.
    Brambilla F, Perna G, Garberi A, Nobile P, Bellodi L.
    Psychoneuroendocrinology; 1995 Feb; 20(1):1-9. PubMed ID: 7838898
    [Abstract] [Full Text] [Related]

  • 4. Stimulatory tests of growth hormone secretion in prepubertal major depression: depressed versus normal children.
    Ryan ND, Dahl RE, Birmaher B, Williamson DE, Iyengar S, Nelson B, Puig-Antich J, Perel JM.
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(6):824-33. PubMed ID: 8083139
    [Abstract] [Full Text] [Related]

  • 5. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S, Ling SY, Leidy JW, Blaine K, Holtzman T.
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [Abstract] [Full Text] [Related]

  • 6. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.
    Coplan JD, Papp LA, Martinez J, Pine D, Rosenblum LA, Cooper T, Liebowitz MR, Gorman JM.
    Am J Psychiatry; 1995 Apr; 152(4):619-22. PubMed ID: 7694915
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.
    Tancer ME, Stein MB, Uhde TW.
    Psychoneuroendocrinology; 1990 Apr; 15(4):253-9. PubMed ID: 2087535
    [Abstract] [Full Text] [Related]

  • 8. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR.
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [Abstract] [Full Text] [Related]

  • 9. Effect of chronic clonidine administration on GH secretion in adult human subjects.
    Catania A, Baldini M, Orsatti A, Airaghi L, Gasparini P, Cantalamessa L.
    Exp Clin Endocrinol; 1991 Mar; 97(1):76-80. PubMed ID: 1907565
    [Abstract] [Full Text] [Related]

  • 10. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H, Riemann D, Stoll S, Berger M, Müller WE.
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [Abstract] [Full Text] [Related]

  • 11. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy.
    Giustina A, Buffoli MG, Bussi AR, Doga M, Girelli A, Pizzocolo G, Pozzi A, Wehrenberg WB.
    Horm Metab Res; 1992 May; 24(5):240-3. PubMed ID: 1398465
    [Abstract] [Full Text] [Related]

  • 12. Twenty-four hour growth hormone secretion in patients with panic disorder.
    Abelson JL, Curtis GC, Uhde TW.
    Psychoneuroendocrinology; 2005 Jan; 30(1):72-9. PubMed ID: 15358444
    [Abstract] [Full Text] [Related]

  • 13. Effect of growth hormone-releasing hormone and clonidine on growth hormone release in type 1 diabetic patients.
    Giampietro O, Ferdeghini M, Miccoli R, Locatelli V, Cerri M, Yanaihara N, Navalesi R, Müller EE.
    Horm Metab Res; 1987 Dec; 19(12):636-41. PubMed ID: 3126122
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone response to growth hormone-releasing hormone and clonidine in young monkeys: correlation with behavioral characteristics.
    Coleman K, Dahl RE, Ryan ND, Cameron JL.
    J Child Adolesc Psychopharmacol; 2003 Dec; 13(3):227-41. PubMed ID: 14642012
    [Abstract] [Full Text] [Related]

  • 15. Pituitary and extrapituitary action sites of the novel nonpeptidyl growth hormone (GH) secretagogue L-692,429 in the chicken.
    Geris KL, Hickey GJ, Berghman LR, Visser TJ, Kühn ER, Darras VM.
    Gen Comp Endocrinol; 1998 Aug; 111(2):186-96. PubMed ID: 9679090
    [Abstract] [Full Text] [Related]

  • 16. Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder.
    Rapaport MH, Risch SC, Gillin JC, Golshan S, Janowsky DS.
    Am J Psychiatry; 1989 Jan; 146(1):92-5. PubMed ID: 2492166
    [Abstract] [Full Text] [Related]

  • 17. Impaired growth hormone secretion in VMH lesioned rats.
    Mori T, Inoue S, Egawa M, Takamura Y, Minami S, Wakabayashi I.
    Int J Obes Relat Metab Disord; 1993 Jun; 17(6):349-53. PubMed ID: 8101181
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone response to growth hormone-releasing hormone and clonidine in depression.
    Gann H, Riemann D, Stoll S, Berger M, Müller WE.
    Biol Psychiatry; 1995 Sep 01; 38(5):325-9. PubMed ID: 7495927
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone-releasing factor stimulation test in depression.
    Krishnan KR, Manepalli AN, Ritchie JC, Rayasam K, Melville ML, Daughtry G, Thorner MO, Rivier JE, Vale WW, Nemeroff CB.
    Am J Psychiatry; 1988 Jan 01; 145(1):90-2. PubMed ID: 2827532
    [Abstract] [Full Text] [Related]

  • 20. Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy.
    Jorgensen EV, Schwartz ID, Hvizdala E, Barbosa J, Phuphanich S, Shulman DI, Root AW, Estrada J, Hu CS, Bercu BB.
    J Pediatr Endocrinol; 1993 Jan 01; 6(2):131-42. PubMed ID: 8102303
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.